The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
Open accessAbstract
Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have a poor prognosis with conventional chemotherapy. In the present study, we retrospectively analyzed the outcome of patients with BPDCN who underwent allogeneic stem cell transplantation (allo-SCT) or autologous stem cell transplantation (auto-SCT). A total of 39 patients (allo-SCT, n = 34; auto-SCT, n = 5) were identified in the European Group for Blood and Marrow Transplantation registry. The 34 allo-SCT patients had a median age of 41 years (range, 10-70) and received transplantations from sibling (n = 11) or unrelated donors (n = 23) between 2003 and 2009. MAC was used in 74% of patients. Nineteen allo-SCT patients (56%) received transplantations in first complete remission. The 3-year cumulative incidence of relapse, disease-free survival, and overall survival was 32%, 33%, and 41%, respectively. By univariate comparison, being in first remission at allo-SCT favorably influenced survival, whereas age, donor source, and chronic GVHD had no significant impact. We conclude that high-dose therapy followed by allo-SCT from related or unrelated donors can provide durable remission even in elderly patients with BPDCN. However, it remains to be shown if graft-versus-malignancy effects can contribute significantly to BPDCN control after allo-SCT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Cited by
Kanate, A. S., Majhail, N. S., Savani, B. N., Bredeson, C., Champlin, R. E., Crawford, S., Giralt, S. A., LeMaistre, C. F., Marks, D. I., Omel, J. L., et al. (2020) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2020.03.002 · Cited by 283
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
Testa, U., Pelosi, E., & Frankel, A. (2014) · Biomarker Research · doi:10.1186/2050-7771-2-4 · Cited by 255
Metadata
- Authors
- Roos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., Iriondo Atienza, A., Arcese, W., Beelen, D. W., Cornelissen, J. J., Kröger, N., Milone, G., Rossi, G., Jardin, F., Peters, C., Rocha, V., Sureda, A., Mohty, M., & Dreger, P.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-01-17
- Volume
- 121
- Issue
- 3
- Pages
- 440-446
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1998650989
- Cited by
- 177
- References
- 1
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. https://app.cochat.ai/papers/10.1182/blood-2012-08-448613
- The paper
- Roos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., Iriondo Atienza, A., Arcese, W., Beelen, D. W., Cornelissen, J. J., Kröger, N., Milone, G., Rossi, G., Jardin, F., Peters, C., Rocha, V., Sureda, A., Mohty, M., & Dreger, P. (2013). Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. https://doi.org/10.1182/blood-2012-08-448613
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.